Taysha Gene Therapies (TSHA) Debt Ratio (2020 - 2026)

Taysha Gene Therapies has disclosed Debt Ratio across 7 years of filings, most recently posting 0.16 for Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.16, down 46.87% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.16 (down 46.87% YoY), and the FY2025 annual result was 0.15, down 46.74% from the prior year.
• Debt Ratio came in at 0.16 for Q1 2026 at Taysha Gene Therapies, up from 0.15 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.91 in Q3 2023 to a low of 0.12 in Q2 2025.
• The 5-year median for Debt Ratio is 0.26 (2022), against an average of 0.29.
• Across the five-year window, Debt Ratio soared 193.69% in 2022 and plunged 73.93% in 2024, its largest moves.
• Taysha Gene Therapies' Debt Ratio stood at 0.3 in 2022, then decreased by 22.0% to 0.23 in 2023, then advanced by 16.84% to 0.27 in 2024, then plunged by 46.74% to 0.15 in 2025, then gained by 11.69% to 0.16 in 2026.
• The last three Debt Ratio figures came in at 0.16 (Q1 2026), 0.15 (Q4 2025), and 0.16 (Q3 2025), per Business Quant data.